ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2019
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Atherosclerosis: X
Atherosclerosis: X is not currently indexed in Scopus. Published by Elsevier Ireland Ltd.
Checked against the index lists dated .
ISSN 2590-1354Verify ISSN ↗
Publisher: Elsevier Ireland Ltd
Scopus · Inactive
0
Indexed in
Cost to publish: About US$2,100 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Atherosclerosis: X indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2019).
What is the impact factor of Atherosclerosis: X?
Atherosclerosis: X has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Atherosclerosis: X?
The publisher lists an article processing charge of about US$2,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Atherosclerosis: X and what is its ISSN?
Atherosclerosis: X is published by Elsevier Ireland Ltd. Its ISSN is 2590-1354.
Is Atherosclerosis: X in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Atherosclerosis: X open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Atherosclerosis: X for 1 year, in 2019. Coverage ended in 2019, 7 years ago, and Scopus now lists the title as inactive.
How well cited is Atherosclerosis: X? — open metrics via OpenAlex
Atherosclerosis: X has an h-index of 0 and a 2-year mean of 0 citations per paper (OpenAlex).
0
h-index
0
2-yr mean citations
0
i10-index
0
works indexed
0
total citations
Publication fee · open access list price, US$
US$2,100
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Atherosclerosis: X? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2019. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2019
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Elsevier Ireland Ltd
Elsevier Ireland Ltd has 54 other titles in our data; 49 are currently indexed in Scopus.
Related journals
8 journals Journal Indexed in
Auris Nasus Larynx Scopus Q2 WoS SCIE Australian Critical Care Scopus Q1 WoS SCIE/SSCI BioSystems Scopus Q1 WoS SCIE Cancer Letters Scopus Q1 WoS SCIE Chemico-Biological Interactions Scopus Q1 WoS SCIE Chemistry and Physics of Lipids Scopus Q2 WoS SCIE Clinical and Translational Radiation Oncology Scopus Q1 WoS SCIE DOAJ Clinical Neurophysiology Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.